CNN: Moderna's clinical trial numbers show there's 'no way' Trump can have a vaccine by Election Day
UC expert leading local trial is encouraged by community response
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine, is featured in an article by CNN on the trial of the Moderna vaccine for COVID-19. In the story, Peter Hotez, MD, a vaccinologist at Baylor College of Medicine and CNN medical expert, says there is "no way" the vaccine will be ready by Election Day Nov. 3 as President Trump is hoping.
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine. Photo/Colleen Kelley/UC Creative + Brand
Fichtenbaum, who is the medical director for the Moderna trial at UC, told CNN he expects to start enrolling patients at his site in the middle of August. He said his goal is to enroll 500 patients, and already 2,500 patients have reached out to him inquiring about the trial.
"We're getting good numbers," he said of the trial. "I think this accrual is going to hit its target pretty quickly."
Read the entire story here.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
The Last Show with David Cooper discusses AI in education with UC’s Joshua Lambert
April 12, 2026
The Last Show with David Cooper, a global news podcast, featured Joshua Lambert, PhD, a professor and biostatistician in UC College of Nursing to discuss his latest research on using artificial intelligence for student advising.
UC enrolls first patients in clinical trial for prosthetic joint infections
April 10, 2026
The University of Cincinnati has enrolled the first patients in Peptilogics’ RETAIN clinical trial, testing an investigational drug for prosthetic joint infections after total knee replacement to reduce repeat surgeries and infection recurrence.
Long before machine guns, ancient Romans used this rapid-fire weapon
April 9, 2026
Smithsonian highlights research by UC Classics Professor Steven Ellis, who supervised archaeological work in the Porta Stabia neighborhood of Pompeii.